Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer

Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer

US Patent 7399469 · Granted Jul 15, 2008

Estimated economic value: $17,851,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Trispecific binding proteins and methods of use2024
Anti-CD40 antibodies2021
Trispecific binding proteins and methods of use2021
Anti-RANKL antibodies and methods of use2019
Anti-CD40 antibodies2018
Anti-IL-6 receptor antibodies and methods of use2018
Trispecific binding proteins and methods of use2017
Anti-CD40 antibodies and methods of use2017
Anti-CD40 antibodies2017
Anti-KDR antibodies and methods of use2016
Methods of inhibiting proliferation of CD40-expressing cancer cells with anti-CD2016
Anti-IL-1β antibodies2015